Perspective Pocfratio from 2010 to 2025

CATX Stock   2.52  0.03  1.20%   
Perspective Therapeutics POCF Ratio yearly trend continues to be fairly stable with very little volatility. POCF Ratio will likely drop to -2.75 in 2025. During the period from 2010 to 2025, Perspective Therapeutics POCF Ratio regression line of annual values had r-squared of  0.12 and arithmetic mean of (99.43). View All Fundamentals
 
POCF Ratio  
First Reported
2010-12-31
Previous Quarter
(2.62)
Current Value
(2.75)
Quarterly Volatility
117.25866334
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Total Revenue of 1.6 M or Gross Profit of 1.3 M, as well as many indicators such as Price To Sales Ratio of 54.85, Dividend Yield of 0.0 or PTB Ratio of 1.22. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Perspective Therapeutics Correlation against competitors.
For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Latest Perspective Therapeutics' Pocfratio Growth Pattern

Below is the plot of the Pocfratio of Perspective Therapeutics over the last few years. It is Perspective Therapeutics' POCF Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Pocfratio10 Years Trend
Slightly volatile
   Pocfratio   
       Timeline  

Perspective Pocfratio Regression Statistics

Arithmetic Mean(99.43)
Geometric Mean34.44
Coefficient Of Variation(117.93)
Mean Deviation85.39
Median(56.91)
Standard Deviation117.26
Sample Variance13,750
Range412
R-Value0.34
Mean Square Error12,988
R-Squared0.12
Significance0.19
Slope8.47
Total Sum of Squares206,244

Perspective Pocfratio History

2025 -2.75
2024 -2.62
2023 -2.91
2022 -28.84
2021 -56.91
2020 -292.09
2019 -103.23

About Perspective Therapeutics Financial Statements

Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Pocfratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
POCF Ratio(2.62)(2.75)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Perspective Stock Analysis

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.